Qiong Zhai1†
Fangyuan Liang2†
Guanlin Yang3†
Zhimin Liu4
Xin Dong5
Ren Bu5Peifeng Xue5Shengsang Na6Xuan Zhang1Pengwei Zhao1
Xiaoning Wang1
Qiang Wei1
Yuewu Wang5*Jingkun Lu1*- 1School of Basic Medicine, Inner Mongolia Medical University, Huhehot, China
- 2School of Pharmaceutical and Environmental Engineering, Nantong Vocational University, Nantong, China
- 3Pharmaceutical Department, Zaozhuang Thoracic hospital (Zaozhuang Cancer Hospital), Zaozhuang, China
- 4Pharmaceutical Department, Chifeng College Affiliated Hospital, Chifeng, China
- 5School of Pharmacy, Inner Mongolia Medical University, Huhehot, China
- 6Medical Innovation Center for Nationalities, Inner Mongolia Medical University, Huhehot, China
A Correction on
Zhuriheng pills improve adipose tissue dysfunction and inflammation by modulating PPARγ to stabilize atherosclerotic plaques
by Zhai Q, Liang F, Yang G, Liu Z, Dong X, Bu R, Xue P, Na S, Zhang X, Zhao P, Wang X, Wei Q, Lu J and Wang Y (2025). Front. Pharmacol. 16:1576521. doi: 10.3389/fphar.2025.1576521
The order of authors in the Author list of the published paper was erroneously given as:
“Qiong Zhai1†, Fangyuan Liang2†, Guanlin Yang3†, Zhimin Liu4, Xin Dong5, Ren Bu5, Peifeng Xue5, Shengsang Na6, Xuan Zhang1, Pengwei Zhao1, Xiaoning Wang1, Qiang Wei1, Jingkun Lu1* and Yuewu Wang5*”
The correct Author list reads:
“Qiong Zhai1†, Fangyuan Liang2†, Guanlin Yang3†, Zhimin Liu4, Xin Dong5, Ren Bu5, Peifeng Xue5, Shengsang Na6, Xuan Zhang1, Pengwei Zhao1, Xiaoning Wang1, Qiang Wei1, Yuewu Wang5* and Jingkun Lu1*”
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Zhuriheng pills, atherosclerotic plaques, the adipose tissue dysfunction and inflammation, PPARγ signaling pathway, the adipose tissue dysfunction, the adipose tissue inflammation
Citation: Zhai Q, Liang F, Yang G, Liu Z, Dong X, Bu R, Xue P, Na S, Zhang X, Zhao P, Wang X, Wei Q, Wang Y and Lu J (2025) Correction: Zhuriheng pills improve adipose tissue dysfunction and inflammation by modulating PPARγ to stabilize atherosclerotic plaques. Front. Pharmacol. 16:1736989. doi: 10.3389/fphar.2025.1736989
Received: 31 October 2025; Accepted: 03 November 2025;
Published: 13 November 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Zhai, Liang, Yang, Liu, Dong, Bu, Xue, Na, Zhang, Zhao, Wang, Wei, Wang and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jingkun Lu, MjAwNzAxMjNAaW1tdS5lZHUuY24=; Yuewu Wang, d3l3aW1tdUAxNjMuY29t
†These authors have contributed equally to this work